Ngā hua rapu - Everitt, Daniel

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid mā Salinger, David H., Subramoney, Vishak, Everitt, Daniel, Nedelman, Jerry R.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of a High-Calorie, High-Fat Meal on the Bioavailability and Pharmacokinetics of PA-824 in Healthy Adult Subjects mā Winter, Helen, Ginsberg, Ann, Egizi, Erica, Erondu, Ngozi, Whitney, Karl, Pauli, Elliott, Everitt, Daniel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis mā Li, Hanbin, Salinger, David H., Everitt, Daniel, Li, Mengchun, Del Parigi, Angelo, Mendel, Carl, Nedelman, Jerry R.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Evaluation of Pharmacokinetic Interaction between PA-824 and Midazolam in Healthy Adult Subjects mā Winter, Helen, Egizi, Erica, Erondu, Ngozi, Ginsberg, Ann, Rouse, Doris J., Severynse-Stevens, Diana, Pauli, Elliott, Everitt, Daniel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis mā Abdelwahab, Mahmoud Tareq, Court, Richard, Everitt, Daniel, Diacon, Andreas H., Dawson, Rodney, Svensson, Elin M., Maartens, Gary, Denti, Paolo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers mā Li, Mengchun, Saviolakis, George A., El‐Amin, Wael, Makhene, Mamodikoe K., Osborn, Blaire, Nedelman, Jerry, Yang, Tian J., Everitt, Daniel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

An Exposure-Response Perspective on the Clinical Dose of Pretomanid mā Nedelman, Jerry R., Salinger, David H., Subramoney, Vishak, Woolson, Rob, Wade, Karen, Li, Mengchun, Everitt, Daniel, Mendel, Carl M., Spigelman, Mel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis mā Diacon, Andreas H., De Jager, Veronique R., Dawson, Rodney, Narunsky, Kim, Vanker, Naadira, Burger, Divan A., Everitt, Daniel, Pappas, Frances, Nedelman, Jerry, Mendel, Carl M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Reply to Kim et al., “Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment” mā Diacon, Andreas H., De Jager, Veronique R., Dawson, Rodney, Narunsky, Kim, Vanker, Naadira, Burger, Divan A., Everitt, Daniel, Pappas, Frances, Nedelman, Jerry, Mendel, Carl M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Clofazimine pharmacokinetics in patients with TB: dosing implications mā Abdelwahab, Mahmoud Tareq, Wasserman, Sean, Brust, James C M, Gandhi, Neel R, Meintjes, Graeme, Everitt, Daniel, Diacon, Andreas, Dawson, Rodney, Wiesner, Lubbe, Svensson, Elin M, Maartens, Gary, Denti, Paolo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines mā Gomez, Gabriela Beatriz, Siapka, Mariana, Conradie, Francesca, Ndjeka, Norbert, Garfin, Anna Marie Celina, Lomtadze, Nino, Avaliani, Zaza, Kiria, Nana, Malhotra, Shelly, Cook-Scalise, Sarah, Juneja, Sandeep, Everitt, Daniel, Spigelman, Melvin, Vassall, Anna

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System mā Demers, Anne-Marie, Venter, Amour, Friedrich, Sven O., Rojas-Ponce, Gabriel, Mapamba, Daniel, Jugheli, Levan, Sasamalo, Mohammed, Almeida, Deepak, Dorasamy, Afton, Jentsch, Ute, Gibson, Mara, Everitt, Daniel, Eisenach, Kathleen D., Diacon, Andreas H.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety and Pharmacokinetics of an Intramuscular Monoclonal Antibody (SB 209763) against Respiratory Syncytial Virus (RSV) in Infants and Young Children at Risk for Severe RSV Disea... mā Meissner, H. Cody, Groothuis, Jessie R., Rodriguez, William J., Welliver, Robert C., Hogg, Geoff, Gray, Peter H., Loh, Richard, Simoes, Eric A. F., Sly, Peter, Miller, Ann K., Nichols, Alice I., Jorkasky, Diane K., Everitt, Daniel E., Thompson, Kathleen A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis mā Conradie, Francesca, Diacon, Andreas H, Ngubane, Nosipho, Howell, Pauline, Everitt, Daniel, Crook, Angela M, Mendel, Carl M, Egizi, Erica, Moreira, Joanna, Timm, Juliano, McHugh, Timothy D, Wills, Genevieve, Bateson, Anna, Hunt, Robert, Van Niekerk, Christo, Li, Mengchun, Olugbosi, Morounfolu, Spigelman, Melvin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicen... mā Tweed, Conor D, Dawson, Rodney, Burger, Divan A, Conradie, Almari, Crook, Angela M, Mendel, Carl M, Conradie, Francesca, Diacon, Andreas H, Ntinginya, Nyanda E, Everitt, Daniel E, Haraka, Frederick, Li, Mengchun, van Niekerk, Christo H, Okwera, Alphonse, Rassool, Mohammed S, Reither, Klaus, Sebe, Modulakgotla A, Staples, Suzanne, Variava, Ebrahim, Spigelman, Melvin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa